On the Pressat website, it was reported that the antiviral medication Codivir recently received emergency approval for use in many countries after it was proven to be effective against the disease.
Zyon Ayni, Founder and CEO of Code Pharma, said in an interview: “From day one, I saw the business and social potential. I was allowed to operate in a market that directly affects public health, and I grabbed the opportunity with both hands. Since then, I have never given up. I continued to invest”.
